Skip to main content
. 2021 Dec 14;41(7):1011–1023. doi: 10.1038/s41388-021-02141-5

Fig. 6. Trp53E177R mutant supports chemotherapy response and improves survival in AML.

Fig. 6

A Exemplary bioluminescence imaging (BLI) pictures of representative albino mice transplanted with leukemia cells of the indicated p53 genotype at indicated time points after start of chemotherapy. B Kaplan–Meier survival plots for control and therapy groups. Trp53+/+ control: n = 15, therapy: n = 16; Trp53–/– control: n = 15, therapy: n = 19; Trp53E177R/E177R control: n = 17, therapy: n = 20; n = 3 independent leukemias per genotype. C Immunohistochemical staining of GFP used as a surrogate marker of leukemia cells in spleens collected from control (left panel) and treated animals (right panel).